| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥202.8B | ¥188.9B | +7.4% |
| Operating Income | ¥3.9B | ¥5.0B | -21.3% |
| Ordinary Income | ¥5.5B | ¥6.4B | -13.7% |
| Net Income | ¥3.7B | ¥4.4B | -16.5% |
| ROE | 3.9% | 4.9% | - |
FY2025 Q3 cumulative results show revenue of 202.8 billion yen (YoY +7.4%), representing top-line growth, but operating income declined 21.3% to 3.9 billion yen. Ordinary income decreased 13.7% to 5.5 billion yen, and net income attributable to owners fell 16.5% to 3.7 billion yen. The profit decline occurred despite revenue expansion, driven by deteriorating operating margin to 1.9% from 2.6% in the prior year. Gross profit margin of 8.1% remains structurally low, while SG&A expenses increased to 12.5 billion yen, compressing profitability. Non-operating income of 1.7 billion yen, including dividend income of 950 million yen and forex gains of 280 million yen, partially offset operating profit weakness. Total assets increased to 192.6 billion yen from 171.0 billion yen, while equity strengthened to 92.8 billion yen from 89.3 billion yen, maintaining an equity ratio of 48.2%. The company faces challenges in translating revenue growth into profit expansion amid rising operating expenses and low gross margins.
Revenue increased 13.9 billion yen or 7.4% YoY to 202.8 billion yen, driven primarily by the Chemicals segment which grew 9.1% to 187.3 billion yen and represents 92.3% of total revenue. The Daily Products segment declined 10.9% to 5.8 billion yen, while Civil Engineering and Construction Materials segment contracted 9.3% to 9.7 billion yen. The revenue expansion in Chemicals reflects volume growth and potentially favorable product mix shifts, though gross margin pressure suggests competitive pricing or input cost inflation. Operating profit declined 1.1 billion yen or 21.3% to 3.9 billion yen despite the revenue gain, indicating significant margin compression. Gross profit increased nominally but gross margin contracted, while SG&A expenses rose in absolute terms, with unallocated corporate costs increasing from 123 million yen to 131 million yen. The operating margin deteriorated 0.7 percentage points to 1.9%, reflecting the inability to leverage revenue growth into profit expansion. Non-operating income contribution of approximately 1.6 billion yen, primarily from investment securities dividend income of 950 million yen and forex gains of 280 million yen, mitigated operating profit weakness to produce ordinary income of 5.5 billion yen, down 13.7% YoY. The gap between operating income and ordinary income narrowed from 1.4 billion yen to 1.6 billion yen, with non-operating income representing approximately 3.0% of revenue. Net income of 3.7 billion yen reflects an effective tax rate of 33.7%. This represents a revenue up, profit down pattern, where top-line growth failed to translate into bottom-line expansion due to margin compression and expense growth outpacing revenue gains.
The Chemicals segment generated revenue of 187.3 billion yen (up 9.1% YoY) and segment profit of 4.8 billion yen (down 8.7% YoY), representing the core business with 92.3% revenue share. Segment margin decreased to 2.5% from 3.0%, indicating pricing pressure or cost inflation despite volume growth. The Daily Products segment recorded revenue of 5.8 billion yen (down 10.9%) and segment profit of 482 million yen (down 38.5%), with margin contracting sharply from 12.0% to 8.3%. This segment shows significant profitability deterioration despite its smaller scale. Civil Engineering and Construction Materials segment reported revenue of 9.7 billion yen (down 9.3%) and segment loss of 34 million yen versus prior year profit of 190 million yen, turning unprofitable. The segment represents 4.8% of revenue but has become a drag on overall profitability. Margin divergence is substantial, with Daily Products historically maintaining higher margins than Chemicals, though both experienced compression. The core Chemicals business demonstrates volume resilience but faces profitability challenges, while smaller segments show more pronounced deterioration in both revenue and margins.
[Profitability] ROE of 3.9% represents a decline from prior levels, calculated as net profit margin of 1.8% multiplied by asset turnover of 1.05 and financial leverage of 2.07. Operating margin of 1.9% deteriorated 0.7 percentage points from 2.6% YoY, while gross margin of 8.1% remains structurally constrained. EBIT margin of 1.9% indicates limited operating efficiency. Net profit margin of 1.8% compares to 2.3% in the prior year. [Cash Quality] Cash and deposits increased to 28.5 billion yen from 25.6 billion yen, providing 3.4 times coverage of short-term debt of 6.0 billion yen and 0.34 times coverage of total current liabilities of 83.5 billion yen. Trade receivables expanded significantly to 76.1 billion yen from 57.5 billion yen, implying days sales outstanding of approximately 137 days, which is elevated and suggests collection elongation. [Investment Efficiency] Asset turnover of 1.05 reflects moderate capital efficiency. Investment securities holdings of 57.5 billion yen represent 29.8% of total assets, contributing non-operating dividend income. [Financial Health] Equity ratio of 48.2% improved from 52.2% due to asset base expansion outpacing equity growth. Current ratio of 153.6% and quick ratio of 146.3% indicate adequate short-term liquidity. Interest-bearing debt stands at 6.0 billion yen entirely in short-term borrowings, producing debt-to-equity ratio of 0.065, indicating conservative leverage. However, short-term debt represents 100% of interest-bearing liabilities, creating refinancing concentration risk. Total liabilities increased to 99.8 billion yen from 81.7 billion yen, with trade payables expanding 41.3% to 70.8 billion yen from 50.1 billion yen, reflecting extended payment terms or increased procurement volume.
Cash and deposits increased 2.9 billion yen YoY to 28.5 billion yen despite declining profitability, suggesting working capital adjustments offset profit weakness. Trade receivables expanded 18.6 billion yen to 76.1 billion yen, representing a significant cash use and indicating either sales mix shift toward longer payment terms or collection efficiency deterioration with DSO extending to approximately 137 days. Electronically recorded monetary claims increased 4.1 billion yen to 20.3 billion yen, further reflecting receivables expansion. Inventory increased modestly by 0.4 billion yen to 5.2 billion yen, maintaining relatively lean inventory management. On the liability side, trade payables increased 20.7 billion yen to 70.8 billion yen, providing substantial working capital financing and partially offsetting receivables expansion. This 41.3% payables increase suggests either procurement volume growth aligned with revenue expansion or negotiated payment term extensions. The net working capital position shows receivables growing faster than payables, consuming cash operationally. Investment securities holdings of 57.5 billion yen remain substantial and relatively stable, generating dividend income of 950 million yen. The company maintains comfortable liquidity with cash coverage of short-term debt at 4.7 times, though the concentration of all interest-bearing debt in short-term maturities creates refinancing exposure. The balance sheet expansion with assets increasing 21.6 billion yen reflects business scale growth, though profitability conversion efficiency declined.
Ordinary income of 5.5 billion yen versus operating income of 3.9 billion yen demonstrates non-operating net contribution of approximately 1.6 billion yen, representing 29.1% of revenue and significantly supporting reported profitability. This comprises primarily dividend income from investment securities of 950 million yen, interest income of 90 million yen, and forex gains of 280 million yen. Non-operating income contribution of 1.6 billion yen represents 3.0% of revenue, indicating material dependency on financial income to supplement weak operating performance. The investment securities portfolio of 57.5 billion yen generates approximately 1.7% yield through dividend income, providing stable non-operating support. Recurring operating profitability remains constrained at 1.9% margin, suggesting core business profitability challenges. No extraordinary items or non-recurring factors were disclosed, indicating reported figures reflect ongoing operations. The material gap of 41% between operating income and ordinary income highlights that core business profitability is significantly weaker than headline earnings suggest. Without operating cash flow disclosure, the cash quality of reported earnings cannot be verified, though the substantial receivables expansion of 18.6 billion yen raises concerns about revenue recognition timing versus cash collection. Earnings quality is constrained by low operating margins, significant non-operating income dependency, and unverified cash conversion.
Full-year guidance projects revenue of 244.6 billion yen, operating income of 4.1 billion yen, ordinary income of 5.9 billion yen, and net income of 4.2 billion yen. Q3 cumulative progress rates stand at 82.9% for revenue, 95.1% for operating income, 92.8% for ordinary income, and 87.8% for net income against full-year targets. Revenue progress of 82.9% exceeds the standard Q3 threshold of 75%, suggesting potential for full-year revenue upside or fourth quarter seasonality factors. Operating income progress of 95.1% significantly exceeds standard expectations, indicating limited room for further profit growth in Q4 and potential full-year underperformance risk if any adverse developments occur. The guidance implies YoY changes of negative 2.2% for revenue, negative 27.5% for operating income, and negative 21.5% for ordinary income, reflecting management's expectation of continued profit pressure despite revenue stabilization. Fourth quarter implied figures suggest revenue of approximately 41.8 billion yen, operating income of 200 million yen, and net income of 510 million yen, representing sequential deceleration from Q3 run rates. The elevated progress rates for profit metrics at 87-95% with one quarter remaining suggest conservative full-year guidance or anticipation of Q4 margin compression. Annual dividend of 39 yen per share maintains continuity with prior periods.
The company plans an annual dividend of 39 yen per share for the fiscal year. Based on Q3 cumulative net income of 3.7 billion yen and approximately 34.2 million shares outstanding (calculated from equity per share), the implied payout ratio stands at approximately 38.2% against Q3 annualized earnings. Against full-year guided net income of 4.2 billion yen, the dividend payout ratio would be approximately 31.7%, indicating sustainable distribution policy. The dividend level maintains consistency with prior periods, providing shareholder return stability despite earnings decline. No share buyback programs were disclosed. Total shareholder return consists solely of dividend payments, with total return ratio matching the payout ratio. The dividend policy appears sustainable given the conservative payout ratio below 40%, though the lack of operating cash flow disclosure creates uncertainty about cash generation adequacy to fund distributions. With cash and deposits of 28.5 billion yen and minimal debt of 6.0 billion yen, the balance sheet provides sufficient cushion to maintain dividends. The stable dividend despite earnings decline suggests management confidence in earnings stabilization or willingness to maintain shareholder returns through the profit cycle.
Gross margin compression and operating leverage deterioration represent the primary profitability risk, with gross margin of 8.1% and operating margin of 1.9% leaving minimal buffer against cost inflation or pricing pressure. The 0.7 percentage point operating margin decline demonstrates vulnerability to expense growth, particularly in the core Chemicals segment where margin contracted from 3.0% to 2.5%. Receivables management and working capital pressure constitute significant cash flow risk, with trade receivables expanding 32.4% to 76.1 billion yen and days sales outstanding extending to approximately 137 days, substantially above the industry median of 73.6 days. This 18.6 billion yen receivables increase represents nearly five times Q3 net income and indicates either customer payment term extensions or collection difficulties. The extended collection cycle increases bad debt exposure and constrains cash flow generation. Short-term debt concentration creates refinancing risk, with 100% of interest-bearing liabilities maturing within one year totaling 6.0 billion yen. While absolute debt levels remain manageable at 6.5% debt-to-equity ratio, the lack of term debt diversification exposes the company to credit market disruptions or bank relationship changes, particularly concerning given working capital consumption trends.
[Industry Position] (Reference - Proprietary Analysis) Profitability: ROE of 3.9% exceeds industry median of 3.7% marginally but falls within the interquartile range of 2.2%-8.4%, positioning the company at median performance. Operating margin of 1.9% significantly underperforms the industry median of 3.2% (IQR: 1.3%-4.6%), ranking in the bottom quartile of the trading sector. Net profit margin of 1.8% slightly trails the industry median of 2.0% (IQR: 1.0%-3.9%). Financial Health: Equity ratio of 48.2% aligns closely with industry median of 47.8% (IQR: 43.0%-55.5%), indicating standard capitalization. Current ratio of 153.6% underperforms the industry median of 188.0% (IQR: 164.0%-238.0%), suggesting relatively tighter liquidity positioning. Financial leverage of 2.07 matches industry median of 1.97 (IQR: 1.80-2.33). Efficiency: Asset turnover of 1.05 performs in line with industry median of 1.06 (IQR: 0.70-1.32). Receivables turnover of approximately 137 days substantially exceeds the industry median of 73.6 days (IQR: 64.8-91.1 days), indicating below-average collection efficiency. Payables turnover of approximately 128 days significantly exceeds the industry median of 64.1 days (IQR: 62.3-80.2 days), reflecting extended payment terms that provide working capital benefit. Growth: Revenue growth of 7.4% YoY outperforms the industry median of 2.6% (IQR: -5.3%-10.8%), positioning in the upper quartile for top-line expansion. The company demonstrates superior revenue growth momentum relative to trading sector peers, though profit conversion lags peers due to margin compression. Net debt to EBITDA positioning is favorable given minimal debt levels, comparing well to industry median of negative 2.14. The company's primary competitive disadvantage lies in operating margin performance and receivables management efficiency. ※ Industry: Trading (15 companies), Comparison: FY2025-Q3, Source: Proprietary analysis
Revenue growth momentum of 7.4% YoY positions the company above trading sector peers (industry median 2.6%), demonstrating market share gains or favorable end-market exposure particularly in the core Chemicals segment which accounts for 92.3% of revenue. However, this top-line strength has not translated into proportionate profit expansion, with operating income declining 21.3% due to margin compression from 2.6% to 1.9%. The company's operating margin of 1.9% ranks in the bottom quartile of the trading sector versus industry median of 3.2%, indicating structural profitability challenges requiring operational efficiency improvements or pricing power restoration. Working capital management shows concerning trends with receivables expanding 32.4% to 76.1 billion yen and collection period extending to approximately 137 days, nearly double the industry median of 73.6 days, consuming significant cash and elevating bad debt risk. The offsetting payables increase of 41.3% to 70.8 billion yen provides temporary working capital relief but creates dependency on supplier credit. Earnings quality requires monitoring given the material 1.6 billion yen non-operating income contribution representing 41% of operating income, primarily from investment securities dividend income, making core business profitability weaker than headline figures suggest. The company maintains financial stability with equity ratio of 48.2% aligned to industry median and minimal leverage at 6.5% debt-to-equity, though 100% short-term debt concentration creates refinancing exposure. Full-year guidance progress rates of 95.1% for operating income and 87.8% for net income with one quarter remaining suggest limited upside potential and risk of guidance achievement challenges if Q4 deteriorates. The stable dividend policy at approximately 32-38% payout ratio remains sustainable given balance sheet strength, providing shareholder return consistency through the profit cycle.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.